Introduced February 4, 2025 by Rep. Dingell with Rep.
James as a co-sponsor, H. Res. 98 expresses support for designating February 4, 2025 as National Cancer Prevention Day.
The measure frames prevention and risk reduction as central to human health, environmental quality, and economic well‑being. The resolution is ceremonial, conveying the House’s stance rather than creating programs or expenditures.
The bill cites 2025 cancer statistics—about 2,041,910 new cancer cases and 618,120 deaths—and highlights the Cancer Moonshot’s call to cut the death rate from cancer by 50 percent over the next 25 years. It then lays out three operative provisions: support for the designation, recognition of efforts to raise awareness and reduce cancer risks, and acknowledgment of the profound impact of cancer on families, with a call to expand knowledge and encourage early detection through collaboration with the medical and scientific communities.
At a Glance
What It Does
Designates February 4, 2025 as National Cancer Prevention Day and expresses House support for that designation. It does not create programs or funding.
Who It Affects
Directly affects House members and staff, national health organizations, medical and scientific communities, and public health entities that organize prevention and awareness efforts.
Why It Matters
Signals national priority for cancer prevention and aligns with ongoing Moonshot aims, potentially guiding private sector and public messaging around risk reduction and early detection.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H. Res. 98 is a simple, ceremonial resolution in the U.S. House of Representatives that designates February 4, 2025 as National Cancer Prevention Day and expresses support for that designation.
The bill emphasizes prevention and reducing cancer risks as core concerns for public health, the environment, and the economy. It notes the 2025 cancer landscape with projected cases and deaths and cites the Cancer Moonshot goal of achieving a 50% reduction in cancer deaths within 25 years.
The resolution includes three operative statements: the House’s support for the designation, recognition of ongoing efforts to raise awareness and reduce cancer risks, and acknowledgment of the devastating impact cancer has on families, with a call to expand knowledge, promote early detection, and collaborate with medical and scientific communities to curb the disease. There are no new programs or funding authorized by this measure; it serves as a formal political signal rather than policy implementation.
The Five Things You Need to Know
The resolution designates February 4, 2025 as National Cancer Prevention Day.
The House expresses support for the designation and for awareness-raising efforts.
It cites 2025 cancer statistics (new cases and deaths) and references the Cancer Moonshot goal.
It calls for expanding knowledge and early detection through collaboration with medical and scientific fields.
No funding or new programs are established by this resolution.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Designation of National Cancer Prevention Day
This section states the House’s intent to designate February 4, 2025 as National Cancer Prevention Day. The mechanism is ceremonial—creating a focal point for prevention messaging across health, environmental, and economic domains without imposing new obligations or funding.
Recognition of prevention awareness efforts
This section recognizes ongoing efforts to raise awareness about reducing cancer risks and acknowledges the role of public health organizations, healthcare providers, researchers, and communities in advancing prevention goals.
Encouragement of collaboration and early-detection emphasis
This section highlights the Cancer Moonshot objective to expand knowledge, promote early detection, and foster collaboration among medical and scientific communities to reduce cancer mortality and improve outcomes for families affected by cancer.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Cancer patients and families gain visibility for prevention and early-detection messaging and may see future preventive initiatives informed by heightened national attention.
- Public health organizations and cancer advocacy groups receive formal recognition that can bolster outreach and partnership opportunities.
- Hospitals, oncology clinics, and primary care systems benefit from a clearer public-health emphasis on prevention and early detection in national discourse.
- Research institutions and Cancer Moonshot partners align with a national priority, potentially facilitating collaboration and information sharing.
- State and local health departments can leverage the designation to coordinate prevention campaigns and community outreach.
Who Bears the Cost
- Congressional staff time and resources to promote the resolution and associated events.
- Public health organizations may incur modest outreach or programmatic costs to participate in prevention messaging reforms.
- Hospitals and clinics might allocate staff time for screening outreach tied to awareness campaigns.
- State and local health departments could bear administrative costs for local events and communications.
- Private sector entities involved in health campaigns may incur marketing or outreach expenses to align with national awareness efforts.
Key Issues
The Core Tension
The central dilemma is whether a ceremonial designation can meaningfully advance cancer prevention and early detection in the absence of new funding or explicit policy changes.
As a ceremonial resolution, HR98 does not authorize funding or create new statutory programs. Its value lies in signaling national priority and shaping public discourse around cancer prevention, early detection, and cross-sector collaboration.
The effectiveness of the designation depends on future policy actions, resource allocations, and coordinated public health campaigns that translate awareness into measurable risk-reduction outcomes.
Core tensions include balancing a symbolic gesture with the need for concrete, funded policies to move prevention forward. Without budgetary support or regulatory changes, the designation’s impact relies on private-sector partnerships and state/local health departments to mobilize prevention efforts and to translate heightened awareness into real-world actions.
The resolution also assumes that increased emphasis on prevention will harmonize with ongoing Moonshot objectives, but it leaves unanswered how those objectives will be funded, measured, or enacted in practice.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.